Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Kidney Neoplasms × Hematologic Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 4 Neoplasms 3 Rectal Neoplasms 2 Polycystic Ovary Syndrome 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Wilms Tumor 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Oligomenorrhea 1 Menstruation Disturbances 1 Kidney Neoplasms 1 Infertility 1 Hyperandrogenism 1 Hirsutism 1 Hip Fractures 1 Hepatic Veno-Occlusive Disease 1 HCC 1 Fibrosis 1 Fatigue 1 Endocrine System Diseases 1 Disease 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Anovulation 1

Interventions

aldesleukin 8 Sunitinib 5 Interferon-alpha 4 Chemotherapy, Adjuvant 4 Blood Specimen Collection 4 pembrolizumab 3 Vincristine 3 Neoadjuvant Therapy 3 Dactinomycin 3 Cyclophosphamide 3 Bevacizumab 3 sargramostim 2 fludarabine phosphate 2 Robotic Surgical Procedures 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Gene Expression Profiling 2 Fluorouracil 2 Etoposide 2 Doxorubicin 2 Carboplatin 2 Amplified Fragment Length Polymorphism Analysis 2 tremelimumab 1 toripalimab 1 temsirolimus 1 spartalizumab 1 pazopanib 1 orantinib 1 motexafin gadolinium 1 keyhole-limpet hemocyanin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04113486 2020-11-24

ENRC

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡